US 9005632
Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 9005632 (Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains) held by Takeda Vaccines, Inc. expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K2039/545, A61K2039/58